We work across academic, clinical, and commercial domains to unlock scalable innovation as we co-create biotech ventures that improve patient outcomes. From therapeutics to diagnostics, we help innovations reach clinical and commercial milestones faster, smarter, and with greater impact.
Source – We scout promising science from universities, tech transfer offices, and founders.
· Oncology
· Inflammation
· Infectious Diseases
· Immunology
· Aging & Regenerative Medicine
o Diagnostics & Enabling Platforms
o Drug Delivery
o Women’s Health
o MedTech
Unlike traditional investors, we don’t just write checks — we roll up our sleeves
Powered by SBH Sciences and ABI-LAB, our founders gain:
From proof of concept to proof of business.
Co-founder of 8 biotech companies; led 8 clinical studies and 1 FDA-approved drug.
Board-certified in Internal Medicine and Hemato-oncology; led 50+ clinical trials
Serial entrepreneur; co-founded 15 companies with multiple successful exits.
Drug developers, regulatory experts, MedTech pioneers, and seasoned founders supporting every venture we build.
• Market Potential – Size, urgency, and fit
• Scientific Validity – MoA, IP position, and feasibility
• Capital Efficiency – ~$20M to commercial inflection
• Exit Strategy – Licensing or acquisition potential
• Founder Fit – Vision, execution, and adaptability
Why SBH BioVenture Works
• Faster than academia alone
• Lower-risk than solo founding
• More strategic than incubators
• Embedded team, not just capital
• Focused on lean, milestone driven growth.
Have a discovery worth building around? [Submit Your Concept” / “Schedule a Call” / “Request More Info]
We build the company with you.
Looking to spin out university IP? [Partner with us]
We bring structure, capital, and teams.
Interested in co-investing or sourcing? [Let’s connect]
We bring de-risked, capital-efficient opportunities.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.